VA
HCM icon

Vident Advisory’s HUTCHMED HCM Stock Holding History

Vident Advisory’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
26,584
+8,858
+50% +$112K ﹤0.01% 1626
2026
Q1 		$265K Buy
+17,726
New +$259K ﹤0.01% 1568
2025
Q4 		– Sell
-10,527
Closed -$166K – 1678
2025
Q3 		$166K Sell
10,527
-847
-7% -$13.9K ﹤0.01% 1575
2025
Q2 		$171K Sell
11,374
-8,354
-42% -$122K ﹤0.01% 1522
2025
Q1 		$297K Buy
19,728
+8,664
+78% +$128K ﹤0.01% 1272
2024
Q4 		$159K Buy
11,064
+58
+0.5% +$1.04K ﹤0.01% 1373
2024
Q3 		$215K Buy
+11,006
New +$199K 0.01% 1284

Other funds holding HCM

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
XC
XY Capital Central, Hong Kong $104M AUM 8% 1-Year Est. Return

Vident Advisory's HCM Position: Q2 2026 in Review

Vident Advisory increased its HUTCHMED (HCM) stake by 50% in Q2 2026, buying an estimated $112K and bringing the position to 26,584 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Vident Advisory first reported a position in HCM in Q3 2024 and has held it in 7 quarters since. The position peaked at $297K in Q1 2025. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.

  • Vident Advisory held 26,584 shares of HUTCHMED worth $286K as of Q2 2026.
  • Vident Advisory bought 8,858 HUTCHMED shares in Q2 2026, an estimated $112K.
  • HUTCHMED made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1626 holding.
  • Vident Advisory first reported a position in HUTCHMED in Q3 2024 and has held it in 7 quarters since.
  • Vident Advisory's HUTCHMED position peaked at $297K in Q1 2025.
  • 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.